Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frequent Xeomin injections for pain in cervical dystonia
2008-005632-32Phase 2Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jun 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of botulinum toxin type A in cervical dystonia (CD), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Change in TWSTRS pain subscore. Started Jun 2009; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on 2008-005632-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005632-32.